EP3710485
And-SEZ6 mótefnis-lyfjaafleiður og notkunaraðferðir
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.5.2019EP published:
31.3.2021EP application number:
19732174.8
EP translation filed:
27.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
29.5.2039Expiry date:
29.5.2026Next due date:
31.5.2026
Title:
ANTI-SEZ6 ANTIBODY DRUG CONJUGATES AND METHODS OF USE
Timeline
Today
30.5.2019EP application
31.3.2021EP Publication
27.4.2021Translation submitted
15.5.2021Registration published
29.5.2026Expires
Owner
Name:
AbbVie Stemcentrx LLCAddress:
1 North Waukegan Road, North Chicago, Illinois 60064, US
Inventor
Name:
LIU, DavidAddress:
Pacifica, California 94044, US
Name:
GAVRILYUK, JuliaAddress:
San Diego,CA 92130, US
Name:
SCHAMMEL, AlexanderAddress:
San Francisco, California 94114, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862678061 PDate:
30.5.2018Country:
US
Classification
Categories:
C07K 16/28, A61K 47/68
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 30.4.2021
Expires: 29.5.2022
Payer: Örn Þór slf.
Number: 4
Paid: 22.4.2022
Expires: 29.5.2023
Payer: Árnason Faktor ehf.
Number: 5
Paid: 12.4.2023
Expires: 29.5.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 12.4.2024
Expires: 29.5.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 6.5.2025
Expires: 29.5.2026
Payer: Árnason Faktor ehf.